Thursday - June 4, 2026
Clinical Trial at Albany Med Contributes to FDA Approval for GLP-1 Drug
June 04, 2026
ALBANY, New York, June 4 -- Albany Medical College issued the following news:

* * *

Clinical Trial at Albany Med Contributes to FDA Approval for New GLP-1 Drug

By Cassie Nelson

When news broke that the FDA had approved Foundayo, a new GLP-1 pill for diabetes and weight loss that doesn't need to be taken on an empty stomach, many people wanted to learn more.

But some Albany Medical Center patients were already familiar with it: . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products